Home
Latest
E-paper
Companies
Industry
Economy
Blueprint
Finance
Markets
Budget
India News
Politics
External Affairs Defence Security
World News
Opinion
Technology
Immigration
Specials
Partner Content
Sports
Cricket
Lifestyle
Entertainment
Social Viral
Health
BS Decoded
Books
Education
Newsletters
Web Stories
BS at 50
Multimedia
Sudoku
Crossword
BS Apps
Management
Indulgence
Premium
Explore Business Standard
BFSI Insight Summit
Events
About Us
BS Support
Popular Search
BSE Healthcare index hits 52-week high, zooms 36% from March low
Dr Reddy's Laboratories, Cipla, and seven other frontline pharma stocks have hit their respective 52-week highs in the past one week
Cipla announces acquisition of nutrition products portfolio from Wanbury
The company has acquired 4 brands namely CPink, CDense, Productiv and Folinine to further strengthen its presence in women's health portfolio
Goa facility issue worsens Cipla's growth worries; stock falls over 3%
India business has been soft given the realignment of the sales channel
Pharma shares in focus; Cipla, Sun Pharma surge over 5%
At 02:59 PM; Nifty Pharma index, the largest gainer among sectoral indices, was up 3.6% as compared to 1.01% rise in the benchmark Nifty 50 index
